Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer
Chemoresistance remains a major obstacle to successful treatment of triple negative breast cancer (TNBC). Identification of druggable vulnerabilities is an important aim for TNBC therapy. Here, we report that SERCA2 expression correlates with TNBC progression in human patients, which promotes TNBC c...
Saved in:
Main Authors: | Minmin Fan (Author), Jian Gao (Author), Lin Zhou (Author), Wenwen Xue (Author), Yixuan Wang (Author), Jingwei Chen (Author), Wuhao Li (Author), Ying Yu (Author), Bo Liu (Author), Yan Shen (Author), Qiang Xu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
by: Hsin-Chih Chen, et al.
Published: (2022) -
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
by: Shuang Zhang, et al.
Published: (2022) -
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
by: Xinxin Rao, et al.
Published: (2024) -
Translocation of IGF-1R in endoplasmic reticulum enhances SERCA2 activity to trigger Ca2+ER perturbation in hepatocellular carcinoma
by: Yanan Li, et al.
Published: (2023) -
Tyrosine Kinases as Druggable Targets in Cancer
Published: (2019)